New International CTEPH Database
| Status: | Active, not recruiting |
|---|---|
| Conditions: | High Blood Pressure (Hypertension) |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/8/2018 |
| Start Date: | February 2015 |
| End Date: | January 2020 |
The New International CTEPH Database is a prospective, observational multi-center disease
registry run by the International CTEPH Association (ICA), which will collect data in chronic
thromboembolic pulmonary hypertension (CTEPH) patients worldwide. The registry will run for
approximately 5 years. Its objective is to provide an overview on epidemiology of CTEPH, mode
of diagnosis and treatment approaches worldwide as well as determinants of long-term outcomes
as measured by New York Heart Association (NYHA) functional class and survival.
The data collected will improve the knowledge and understanding of this condition, support
the further development of diagnosis and treatment guidelines for patients with CTEPH, and
contribute to improving patient care in the long-term.
registry run by the International CTEPH Association (ICA), which will collect data in chronic
thromboembolic pulmonary hypertension (CTEPH) patients worldwide. The registry will run for
approximately 5 years. Its objective is to provide an overview on epidemiology of CTEPH, mode
of diagnosis and treatment approaches worldwide as well as determinants of long-term outcomes
as measured by New York Heart Association (NYHA) functional class and survival.
The data collected will improve the knowledge and understanding of this condition, support
the further development of diagnosis and treatment guidelines for patients with CTEPH, and
contribute to improving patient care in the long-term.
Inclusion Criteria:
- Patients must be newly diagnosed with chronic thromboembolic pulmonary hypertension
(CTEPH) (incident patients)
- Patients must have been treated with anti-coagulation for at least 3 months before
diagnosis of CTEPH
- Patients must be willing to provide informed consent
- Patients must meet the following criteria for CTEPH:
- Mean pulmonary artery pressure (PAP) ≥ 25 mmHg at rest
- Abnormal VQ scan, pulmonary angiogram, computed tomography (CT) pulmonary
angiogram, or magnetic resonance (MR) pulmonary angiogram confirming chronic
thromboembolic disease as recommended by standard guidelines
Exclusion Criteria:
- None specified
We found this trial at
4
sites
Cleveland Clinic Cleveland Clinic is committed to principles as presented in the United Nations Global...
Click here to add this to my saved trials
University of Maryland As a globally-connected university offering a world-class education, the University of Maryland...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials